by Camille Bello | Jun 2, 2026 | News & Events
PRI, the Pharmabiotic Research Institute, and IPA Europe, representing the European probiotic industry, provide supporting information and legal references on the status of isolated microbial strains to avoid unintended impacts on research, innovation, and European...
by Camille Bello | Jun 19, 2025 | News & Events
In 2024, the European Commission launched a legislative initiative to establish the “EU Biotech Act,” with the ambitious goal of accelerating the transition of biotechnology products from research to market, while maintaining high safety standards for people and the...
by celine PRI | Apr 15, 2025 | News & Events
We are pleased to announce that Camille Bello has joined the Pharmabiotic Research Institute (PRI) as Membership and Communication Manager. Camille brings over a decade of experience in journalism, strategic communication, and stakeholder engagement, along with a...
by celine PRI | Feb 13, 2025 | News & Events
The Pharmabiotic Research Institute (PRI) is pleased to announce the election of Eleni Tsompanidou (Winclove Probiotics) as the new President of the Board of Directors and Executive Committee. Eleni was elected by the PRI Board Members during the latest meeting held...
by PRI | Sep 5, 2024 | News & Events
The Pharmabiotic Research Institute, as a partner of the Human Microbiome Action Consortium, is pleased to announce the publication of the paper, “State of the art and the future of microbiome-based biomarkers: a multidisciplinary Delphi consensus”, J....
by PRI | Apr 9, 2024 | News & Events
Last month over 160 attendees joined together in Lille, France for the 9th annual Pharmabiotics Conference & Partnering event organized by PRI and I-Squared Communications. The 2024 edition focused on the theme of ‘An Evolving Regulatory Landscape for...
